Drug Trial Radar · NCT06570291
Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis
Last checked: Nov 19, 2026Latest source record: Jul 16, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
520
Planned (sponsor's estimate)
Start
Feb 28, 2025
Primary completion
Dec 2026
Study completion Dec 2028
Sponsor
- Lead sponsor
- Wuxi Cellular Biopharmaceutical Group Ltd.Industry
- Sponsor type
- Industry
- First posted
- Aug 26, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 40 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Evaluate the efficacy and safety of Allogenic Adipose Tissue-Derived Mesenchymal Stem Cells Therapy
Conditions
- Knee Osteoarthritis
Interventions
Mesenchymal Stem CellsDrug
Allogenic adipose tissue-derived mesenchymal stem cells administrated for intra- articular use
Sodium Hyaluronate InjectionDrug
Sodium Hyaluronate administrated for intra-articular use
Primary outcomes
What the sponsor says the trial is designed to measure.
- WOMAC scoreTime frame: 48 weeks
- MRI quantitative analysis of articular cartilageTime frame: 24 weeks
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, China · Not yet recruiting
RenJi Hospital
Shanghai, China, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.